Navigation Links
Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
Date:8/4/2008

ned Virologic Response (ITT)*

Treatment Arm All patients

No P/R Lead-in 28 Weeks 55% (59/107)

P/R Lead-in 28 Weeks 56% (58/103)

No P/R Lead-in 48 Weeks 66% (68/103)

P/R Lead-in 48 Weeks 74% (76/103)

P/R Control 48 Weeks 38% (39/104)

P/R Lead-in equals PEGINTRON and REBETOL for 4 weeks prior to the addition of boceprevir

P/R Control equals PEGINTRON and REBETOL alone for 48 weeks

* SVR 12 for 48 week arms; SVR 24 for 28 week arms(1-3)

"These top-line results further validate this novel treatment paradigm and the design of our pivotal Phase III studies of boceprevir, one in treatment-naive patients and one in patients who had failed prior treatment, in which all patients will receive 4 weeks of PEGINTRON and REBETOL prior to the addition of boceprevir," said Thomas P. Koestler, Ph.D., executive vice president and president of Schering-Plough Research Institute. "Additionally, this strategy has the potential to reduce the likelihood of the development of resistance by identifying patients who are responders to interferon and ribavirin prior to their receiving a protease inhibitor."

The rationale for this novel treatment regimen is based on the fact that both PEGINTRON and REBETOL reach steady-state concentrations by week 4, so patients have the protease inhibitor added at a time when the backbone drug levels have been optimized. In addition, the patient's immune system will have been activated and primed by PEGINTRON at the time that boceprevir is added to the regimen. This approach may minimize the period of time when there is a "functional monotherapy" with a direct antiviral, potentially reducing the likelihood for the development of resistance.

The HCV SPRINT-1 study was conducted at sites across the United States, Canada and Europe. Overall, 77
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
2. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
3. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
4. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
5. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
6. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
7. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
8. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
9. Schering-Plough Reports Top-Line Results of the IDEAL Study
10. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
11. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 The report "Silage Inoculants ... (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type ... Silage Inoculants & Enzymes Market is expected to reach ... from 2015 to 2020. Browse 75 ... 194 P ages and an in-depth ...
(Date:7/2/2015)... China , 2. Juli 2015 ... für DNA-Screening in Hongkong vom American College ... in Hongkong ist das erste klinische Next-Generation-Sequencing ... ein CAP-Zertifkat erhält und somit die ... zu den bestehenden US FDA - 21 ...
(Date:7/2/2015)... CHICAGO, Ill. , July 2, 2015  AbbVie ... financial results on Friday, July 24, 2015, before the ... webcast of the earnings conference call at 8 a.m. ... through AbbVie,s Investor Relations website at www.abbvieinvestor.com . ... after 11 a.m. Central time. About AbbVie ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/2/2015)... , ... July 02, 2015 , ... Global leader and ... in compression socks designed for men. , For style that’s quick on its ... daily routine. This is great news for men everywhere because a simple change in ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... 2015” provides comprehensive information on the pipeline products with comparative analysis of ... wound therapy (NPWT) with 22 market data tables and 4 figures, spread ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
(Date:7/2/2015)... ... ... Hand sanitizers have become extremely popular with an annual industry growth rate ... and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of disease ... must be applied correctly and users must be aware of its limitations. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes ... manufacturers. The report is a valuable source of guidance and direction for companies ... Chinese market for the Gelatin Capsule industry including capacity, production, production value, cost ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... on Inc. 5000 list ... and new members, DOVER, N.H., Aug. 25 ... Free" atmosphere and friendly prices, earned,the top spot among ... 5,000 fastest-growing private businesses in the United States., ...
... consulting with school staff on avoidance strategies , , MONDAY, ... staff need to take measures to ensure the safety ... food allergies, says the American Academy of Allergy, Asthma ... and school staff is a key ingredient to keeping ...
... Aug. 25 Researchers at Scripps Translational,Science Institute (STSI) ... of a gene responsible for the majority of inherited ... online Aug. 24 in,Nature., Neuroblastoma -- a cancer ... childhood cancer deaths and has bleak survival probabilities of,less ...
... Integrated EHR Leader,s Growth Up 47 Percent from ... Greenway Medical Technologies,Inc., further establishing itself as ... practice management and interoperability,solutions, recently announced a 47 ... ending June 30, 2008, as compared to fiscal ...
... General Assembly for Allowing Dependents Ages,19-26 to Get Covered ... The face of a,broken health care system keeps ... are now the largest segment of the population without,health ... to change that by allowing more people in their ...
... N.Y., Aug. 25 Reflecting the expanding,scope of ... social, cultural,and environmental factors on health care systems ... Mary Ann Liebert Inc. have renamed,the peer-reviewed journal ... name of the journal (formerly Disease Management) begins ...
Cached Medicine News:Health News:N.H.-Based Health Club Operator Sets The Industry's Pace 2Health News:Food Allergy Action Plan Can Keep Kids From Harm 2Health News:Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 2Health News:Greenway Medical Technologies' Growth Continues with Significant Fiscal Year 2008 Gains 3Health News:Younger Adults in Illinois Aided by Expansion of Health Care Coverage 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: